Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping

Robert Janowski, Maciej Kozak, Elzbieta Jankowska, Zbigniew Grzonka, Anders Grubb, Magnus Abrahamson, Mariusz Jaskolski

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

339 Citeringar (SciVal)
340 Nedladdningar (Pure)


The crystal structure of human cystatin C, a protein with amyloidogenic properties and a potent inhibitor of cysteine proteases, reveals how the protein refolds to produce very tight two-fold symmetric dimers while retaining the secondary structure of the monomeric form. The dimerization occurs through three-dimensional domain swapping, a mechanism for forming oligomeric proteins. The reconstituted monomer-like domains are similar to chicken cystatin except for one inhibitory loop that unfolds to form the open interface of the dimer. The structure explains the tendency of human cystatin C to dimerize and suggests a mechanism for its aggregation in the brain arteries of elderly people with amyloid angiopathy. A more severe conformational disease is associated with the L68Q mutant of human cystatin C, which causes massive amyloidosis, cerebral hemorrhage and death in young adults. The structure of the three-dimensional domain-swapped dimers shows how the L68Q mutation destabilizes the monomers and makes the partially unfolded intermediate less unstable. Higher aggregates may arise through the three-dimensional domain-swapping mechanism occurring in an open-ended fashion in which partially unfolded molecules are linked into infinite chains.
Sidor (från-till)316-320
TidskriftNature Structural Biology
StatusPublished - 2001

Ämnesklassifikation (UKÄ)

  • Farmakologi och toxikologi
  • Läkemedelskemi


Utforska forskningsämnen för ”Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här